As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth ...
The “Before” and “After” photos are breaking the internet. Facebook groups, Reddit threads and gobs of other social media ...
An update from Anatara Lifesciences Ltd ( ($AU:ANR) ) is now available. Anatara Lifesciences faced challenges in 2025, notably with the GaRP-IBS ...
Most analysts predict the market for new weight loss drugs such as Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. Stream NBC 5 for free, 24/7, ...
WASHINGTON—The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed ...
Scientists discovered that people taking weight loss medications regained pounds weeks after they stopped taking the drugs. More than 1,000 people participated in a study and their lifestyle habits ...
India Today on MSN
Popular anti-obesity drug Wegovy prices slashed by 37% in India
Novo Nordisk has reduced the prices of Wegovy by 37%. The obesity pen's lowest dose of 0.25 mg will sell at Rs 10,850 for a ...
SAN ANTONIO — Weight loss treatments aren’t reaching many of the people who need them most due to coverage barriers, new data suggested. Findings from three studies presented on November 5 at The ...
"Given the escalating obesity rates, especially severe obesity among women, and the growing popularity of anti-obesity medications, exploring the association between anti-obesity medication and ...
For 25 years, I’ve served as a rehabilitation counselor for the deaf at MassAbility, a state agency that helps individuals with disabilities find employment and live independently. I’m also the ...
Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic. Hamlet Gasoyan, PhD, researcher at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results